A Prediction Model of 28-day Mortality in Septic Shock
NCT04915625 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 530
Last updated 2021-06-07
Summary
This clinical study adopts the design of cohort research, selects the sepsis shock patients admitted to our hospital ICU as the research object, takes the 28-day mortality rate as the outcome index, collects the baseline data of the patient, the severity of the disease, vital signs, the main infection site, the laboratory-related index, the treatment method and other data, screens out the risk factors affecting the sepsis shock 28-day mortality rate and constructs the prediction model accordingly, analyzes the prediction model with the subject's working characteristic curve (ROC). The recognition ability of the model is calculated by the area under the ROC curve (AUC) and the ability of the model to predict 28-day mortality with SOFA and APACHE II.
Conditions
- Septic Shock
Sponsors & Collaborators
-
Second Affiliated Hospital, School of Medicine, Zhejiang University
lead OTHER
Principal Investigators
-
ZHIJUN XU, MS · 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-12-01
- Primary Completion
- 2021-12-31
- Completion
- 2022-12-31
Countries
- China
More Related Trials
-
Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Sepsis
NCT05229328 ·Status: UNKNOWN
-
Comparing an Automated to a Conventional Sepsis Clinical Prediction Rule
NCT01505478 ·Status: WITHDRAWN
-
Evaluation of Parameters Collected From Routine Data for the Diagnosis of Sepsis and Septic Shock and Their Influence on Time to Diagnosis and Patient Outcome
NCT05383963 ·Status: RECRUITING
-
Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis
NCT06491966 ·Status: RECRUITING
-
Application of Biomarkers Change to Predict Outcome of Patient With Severe Sepsis
NCT02871895 ·Status: UNKNOWN
-
Anisodamine Critically Ill SeptIc Shock
NCT02442440 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Retrospective Review of a Comprehensive Cohort of Septic Shock: Assessment of Critical Determinants of Outcome
NCT01775956 ·Status: UNKNOWN
-
Objective Sepsis Identification Tool to Study Sepsis Epidemiology
NCT04114214 ·Status: COMPLETED
-
Host Dysregulation-Driven Sepsis Prediction Model
NCT06523075 ·Status: COMPLETED
-
Prospective Validation of Clini-biological Parameters Including Initial Hemostasis, Which Improve the Prediction of Death at 1 Month Among Patients With Septic Shock
NCT01231672 ·Status: COMPLETED
-
Risk Factors for Adverse Outcomes in Sepsis
NCT06541600 ·Status: COMPLETED
-
Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)
NCT02803346 ·Status: UNKNOWN
-
Derivation and Validation of a Prognostic Model for Septic Patients at Hospital Admission
NCT03601767 ·Status: UNKNOWN
-
The Impact of Sepsis on Long-term Outcomes in Critical Ill Children With Sepsis
NCT06323226 ·Status: RECRUITING
-
Hemodynamic Evaluation Using Microcirculation for Early Treatment of Septic Patients
NCT06910891 ·Status: RECRUITING ·Phase: NA
-
Prolonged Intravenous Infusion of β-lactam Antibiotics in Early Septic Patients
NCT05024565 ·Status: UNKNOWN ·Phase: NA
-
Epidemiology of Sepsis in China
NCT02448472 ·Status: COMPLETED
-
Construction of a Database for the Life-cycle Sepsis-specific Disease Cohort
NCT04872010 ·Status: UNKNOWN
-
The Application of SERS and Metabolomics in Sepsis
NCT02213237 ·Status: UNKNOWN
-
A Prospective Observational Study of Sepsis
NCT05309889 ·Status: UNKNOWN
-
Clinical Trial to Evaluate MDW for Early Detection of Sepsis
NCT06267742 ·Status: ACTIVE_NOT_RECRUITING
-
The Role of NLR in the Diagnosis and Prognosis of Sepsis
NCT05636202 ·Status: COMPLETED
-
Septic Shock-induced Immunosuppression
NCT04067674 ·Status: RECRUITING
-
Procalcitonin Monitoring Sepsis Study
NCT01523717 ·Status: COMPLETED
-
Serial Body Composition Change for Risk Prediction and Nutritional Guide in Treating Patients With Sepsis
NCT04989569 ·Status: COMPLETED ·Phase: NA